Patients receiving a new breast cancer diagnosis should be queried about their preference for mode of communication and timeliness and efforts should be made to comply by physician practices. This according to a survey of 1,000 patients that sought to determine if there was a difference between actual and preferred care for disclosure to test results. Survey details included:
• Analysis was restricted to 784 breast cancer survivors (89% white, 78% college educated, and media “savvy”).
• 309 (39%) of 784 patients received face-to-face communication for a new cancer diagnosis, with 394 (50%) patients preferring this option.
• 315 (40%) of 784 patients received their cancer biopsy result within 2 days, with 646 (82%) patients preferring this option.
• Differences were identified between actual and preferred care for multiple other test types.
Citation: Attai D, Hampton R, Staley AC, Borgert A, Landercasper J. What do patients prefer? Understanding patient perspectives on receiving a new breast cancer diagnosis. [Published online ahead of print June 15, 2016]. Ann Surg Oncol. doi:10.1245/s10434-016-5312-2.